These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17511228)

  • 1. [Bernstein test].
    Konda Y
    Nihon Rinsho; 2007 May; 65(5):884-9. PubMed ID: 17511228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical?
    Armstrong D; Emde C; Inauen W; Blum AL
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():3-13. PubMed ID: 1577393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Esophageal pH monitoring].
    Yamamoto T
    Nihon Rinsho; 2007 May; 65(5):877-83. PubMed ID: 17511227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F; Pace M
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):423-7. PubMed ID: 20678016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
    Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
    Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
    Williams JF; Sontag SJ; Schnell T; Leya J
    Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain.
    Mousavi S; Tosi J; Eskandarian R; Zahmatkesh M
    J Gastroenterol Hepatol; 2007 Feb; 22(2):218-21. PubMed ID: 17295874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.
    Wiener GJ; Richter JE; Copper JB; Wu WC; Castell DO
    Am J Gastroenterol; 1988 Apr; 83(4):358-61. PubMed ID: 3348191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression.
    Sarkar S; Thompson DG; Woolf CJ; Hobson AR; Millane T; Aziz Q
    Am J Gastroenterol; 2004 Oct; 99(10):1998-2006. PubMed ID: 15447763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical assessment of the current status of non-erosive reflux disease.
    Armstrong D
    Digestion; 2008; 78 Suppl 1():46-54. PubMed ID: 18832840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of GERD--peculiarity of NERD].
    Kinoshita Y; Furuta K; Adachi K
    Nihon Rinsho; 2007 May; 65(5):822-8. PubMed ID: 17511219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of clinical value of Bernstein test and attempts of its modification.
    Waszczuk E
    Mater Med Pol; 1992; 24(3):156-9. PubMed ID: 1307643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.